CHICAGO, Feb. 14, 2013 /PRNewswire-USNewswire/ -- Jordan never planned for his life to turn down a path of drug addiction. At a young age, his life became more difficult after a life-changing tragedy: the sudden passing of Jordan's father. Consequently, Jordan's family started to move from place to place and his mother began dating. Feeling abandoned, by the age of 13 Jordan began using drugs to escape his unhappiness. After years of drug experimentation, Jordan first tried heroin when he was 18 years old.
"Once I started using heroin, there was no stopping it. Within six months, my heroin dosage multiplied by three times," explains Jordan.
According to the Centers of Disease Control, 100 people die from drug overdoses every day in the United States. Lucky for Jordan, he grew tired of living the way he was before becoming a statistic.
Today, Jordan sees things much differently. After seven years of heavy drug abuse, from marijuana and crystal meth to crack and heroin, and trouble with his relationships, work and the law, he turned to the Gateway Foundation Alcohol & Drug Treatment Center in Caseyville, IL, to help him put the use of heroin and other drugs behind him. Jordan is now 20 years old and in recovery.
Jordan chose Gateway Foundation Alcohol & Drug Treatment to help him with his drug addiction because of its integrated treatment approach, which includes medication assisted therapy. To manage the intense cravings and withdrawal symptoms that occur when heroin use stops, Jordan was prescribed a medication called Suboxone® along with the substance abuse counseling, therapy and education he received at Gateway Foundation.
"Using Suboxone® was a tremendous help. My mind wasn't focused on getting heroin, and it helped me through the symptoms of physical withdrawal. Getting the medicine, therapy and counseling at the same place, from the same team was both reassuring and convenient," says Jordan.
Reducing the Likelihood for Relapse
When medication assisted treatment is part of an integrated drug treatment program, the likelihood of a person staying in treatment and remaining drug free is increased. Treatment for dependency on opiates, alcohol or other substances can include the use of a few medications, including Vivitrol® and Suboxone. Gateway physicians and clinicians work closely with individuals to help determine the most appropriate drug treatment plan for them.
"At Gateway Foundation, we educate people like Jordan in intensive outpatient and residential treatment about medication assisted treatment options because they work and save lives. We make our clients aware of their options, benefits and potential risks. As a result, we are seeing that clients are considerably more receptive to how medication assisted treatment might work in their circumstances," explains Gateway Foundation Caseyville Executive Director Don Bushnell .
In addition to prescribed medications, counseling helps individuals increase their motivation for recovery and enhance their overall quality of life. It also helps people develop the skills they need to recognize events that may trigger their use of drugs or alcohol and how to cope with those situations in a healthy way.
For questions regarding Gateway Foundation's integrated treatment programs, including medication assisted treatment, please call the 24-Hour Helpline at 877-505-HOPE (4673) or visit RecoverGateway.org.
About Gateway Foundation Alcohol & Drug Treatment
Gateway Foundation Alcohol & Drug Treatment is Illinois' largest provider of substance abuse treatment, providing services for adults and adolescents at treatment centers throughout the state. Gateway is licensed by the state of Illinois and accredited by The Joint Commission, the leading accrediting organization for hospitals and behavioral healthcare organizations. Each year, Gateway Foundation helps thousands of individual's successfully complete treatment. To learn more about Gateway Foundation's free and confidential consultation, call 877-505-HOPE (4673).
|SOURCE Gateway Foundation Alcohol & Drug Treatment|
Copyright©2012 PR Newswire.
All rights reserved